| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/12/2011 | CN101940755A Chinese medicinal preparation for treating coronary heart disease |
| 01/12/2011 | CN101940751A Traditional Chinese medicinal preparation for treating sequela of cerebral infarction |
| 01/12/2011 | CN101940711A Traditional Chinese medicinal composition for curing coronary disease |
| 01/12/2011 | CN101940705A Traditional Chinese medicine for treating diabetic heart disease |
| 01/12/2011 | CN101940682A Chinese medicinal preparation for treating high blood pressure |
| 01/12/2011 | CN101940671A Medicament for treating heart disease |
| 01/12/2011 | CN101940660A Chinese medicament for treating diabetic retinopathy |
| 01/12/2011 | CN101940640A Method for preparing medicinal composition for treating coronary heart disease |
| 01/12/2011 | CN101940633A Medicament for treating cerebral infarction |
| 01/12/2011 | CN101940616A Preparation method of effective part of Clinopodium chinense (Benth.) O. Kuntze for preventing and treating diabetes and medicine application thereof |
| 01/12/2011 | CN101940610A Preparation method of astragalus extractive |
| 01/12/2011 | CN101940605A Chinese loropetalum leaf total flavonol extract and medical application thereof |
| 01/12/2011 | CN101940601A Leech extract dispersible tablets for treating cerebrovascular disease and preparation method thereof |
| 01/12/2011 | CN101940600A Product for treating hemorrhoid and production method thereof |
| 01/12/2011 | CN101940594A Preparation for treating ischemic cardiovascular diseases and preparation method thereof |
| 01/12/2011 | CN101940593A Preparation for treating ischemic diseases caused by peripheral atherosclerosis and preparation method thereof |
| 01/12/2011 | CN101940592A Preparation for treating ischemic cerebrovascular disease and preparation method thereof |
| 01/12/2011 | CN101940591A Preparation for promoting revascularization or angiogenesis and preparation method thereof |
| 01/12/2011 | CN101940589A Medicament for preventing and treating neurologic damage and related diseases thereof |
| 01/12/2011 | CN101940584A Use of isoflavone compound |
| 01/12/2011 | CN101940580A Health promotion wine for regulating blood fat and preparation method thereof |
| 01/12/2011 | CN101940579A Process for extracting and separating Angoroside C from radix scrophulariae and novel medical application of Angoroside C |
| 01/12/2011 | CN101940571A Anti-angiogenic agents and methods of use |
| 01/12/2011 | CN101940570A Composite of ligustrazine phosphate and danshensu and application thereof |
| 01/12/2011 | CN101940568A Application of indole-3-methanol, diindolylmethane and derivatives thereof in preparing medicament for treating cardiac failure caused by anthracycline |
| 01/12/2011 | CN101940564A Water-soluble coenzyme Q10 combination and preparation method thereof |
| 01/12/2011 | CN101940552A Chinese medicament shikimic acid powder injection |
| 01/12/2011 | CN101940419A Novel health-care pillow |
| 01/12/2011 | CN101703524B Quality control method for leech and preparation containing leech |
| 01/12/2011 | CN101632672B Compound medicinal composition for treating hypertension |
| 01/12/2011 | CN101601765B Anal-intestinal health lotion and preparation method thereof |
| 01/12/2011 | CN101591301B Preparation method of 3, 5-dihydroxy heptyl-6-gadoleic acid derivative |
| 01/12/2011 | CN101554466B Drug for treating coronary heart disease |
| 01/12/2011 | CN101554375B Pharmaceutical composition containing clopidogrel and carbazochrome sodium sulfonate |
| 01/12/2011 | CN101550107B Method for preparing telmisartan |
| 01/12/2011 | CN101518557B Preparation method of apium graveolen capsules |
| 01/12/2011 | CN101461824B Solution for eliminating hemorrhoids |
| 01/12/2011 | CN101450041B Nano lycorine chloride microcapsule latex and preparation method thereof |
| 01/12/2011 | CN101406569B Chinese medicinal composition for treating cerebrovascular disease, and preparation thereof |
| 01/12/2011 | CN101371877B Qi tian dropping pill extract and Qi tian dropping pill as well as method for producing the same |
| 01/12/2011 | CN101327214B Medicine use of isoquinoline alkaloids as tissue factor inhibitor |
| 01/12/2011 | CN101288677B Puerarin derivatives powder injection and its production method |
| 01/12/2011 | CN101288649B Preparation technique of sodium phosphocreatine powder and injection preparation |
| 01/12/2011 | CN101269079B Emulsion composition comprising prostaglandin E1 |
| 01/12/2011 | CN101214323B Orally-taken powder medicine and externally-applied plaster for treating angitis and preparation thereof |
| 01/12/2011 | CN101190906B Method for preparing carthamin yellow carthamus B and application thereof |
| 01/12/2011 | CN101185669B Medicine composition for treating cardiovascular and cerebrovascular diseases |
| 01/12/2011 | CN101181498B Chinese medicine prescription for reducing blood pressure as well as manufacturing method |
| 01/12/2011 | CN101176769B Pharmaceutical composition of cattail pollen and red orpin |
| 01/12/2011 | CN101167775B Method for extracting chrysanthemum total flavone |
| 01/12/2011 | CN101094851B Novel compound having lipase inhibitory activity |
| 01/12/2011 | CN101084913B Application of ophiopognin saponin D in preparing vascular endothelial cells regulating signal transduction gene medicine |
| 01/12/2011 | CN101029022B Process for the preparation of 4-phenoxy quinoline derivatives |
| 01/11/2011 | US7868225 Artichoke hybrid named ‘PS-H2015’ |
| 01/11/2011 | US7868044 FDA Orange book listed patent for adapalene (title compound); topical treatment using aqueous gels, creams, lotions or solutions with at least one polymeric emulsifier, modified cellulose, gum, starch, biopolymer or alginate; better therapeutic efficacy and good tolerance |
| 01/11/2011 | US7868028 blocking voltage-sensitive sodium channels of neurons in a mammal comprising administering 1-benzyl-2-imino-3-(2-hydroxy-3-phenoxypropyl)benzimidazole; analgesics; neuroprotectants; anticonvulsants |
| 01/11/2011 | US7868002 Deazapurines and uses thereof |
| 01/11/2011 | US7867997 δ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 01/11/2011 | US7867996 a crystal stuctured form of 3-{3-[{[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino]-propyl}-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one hydrochloride, useful as bradycardial agents |
| 01/11/2011 | US7867995 βd-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 01/11/2011 | US7867994 reacting 3-[2-(1,3-dioxolan-2-yl)ethyl]-7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one, with 7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]-N-methylmethanamine hydrochloride, in the presence of hydrogen and palladium supported on carbon, to give ivabradine hydrochloride; bradycardial agents |
| 01/11/2011 | US7867986 Enhanced drug delivery in transdermal systems |
| 01/11/2011 | US7867516 Tablet with masked odor or bitterness; especially with a photostabilizer |
| 01/11/2011 | CA2577310C Methods and compositions for oral delivery of fts |
| 01/11/2011 | CA2472149C New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments |
| 01/11/2011 | CA2471766C Compositions for improving lipid metabolism |
| 01/11/2011 | CA2469876C Benzothiazoles |
| 01/11/2011 | CA2462390C Anthranilic acid amides and pharmaceutical use thereof |
| 01/11/2011 | CA2453996C Injectable pharmaceutical formulations |
| 01/11/2011 | CA2453974C 4-(benzylideneamino)-3-(methylsulfanyl)-4h-1,2,4-triazin-5-one derivatives having a pde iv-inhibiting and tnf-antagonistic action for the treatment of heart diseases and allergies |
| 01/11/2011 | CA2451678C Azaindoles |
| 01/11/2011 | CA2439756C Substituted aminodicarboxylic acid derivatives with pharmaceutical properties |
| 01/11/2011 | CA2436891C Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 01/11/2011 | CA2429781C Linkable sialyl lewis x analogs |
| 01/11/2011 | CA2420592C Fused pyrrolocarbazoles against inflammation |
| 01/11/2011 | CA2400486C Aniline-derived ligands for the thyroid receptor |
| 01/11/2011 | CA2387095C Compound with growth hormone releasing properties |
| 01/11/2011 | CA2385592C Benzamides and related inhibitors of factor xa |
| 01/11/2011 | CA2340227C Method and pharmaceutical composition for reducing serum homocysteine concentration |
| 01/11/2011 | CA2328990C N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 01/11/2011 | CA2309541C Vegi, an inhibitor of angiogenesis and tumor growth |
| 01/11/2011 | CA2156360C Adhesion receptor antagonists |
| 01/10/2011 | CA2709624A1 Immediate release dosage form of bosentan and process of manufacturing such |
| 01/10/2011 | CA2671778A1 Immediate release dosage form of bosentan and process of manufacturing such |
| 01/06/2011 | WO2011002917A1 Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as a2a r agonists |
| 01/06/2011 | WO2011002910A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/06/2011 | WO2011002696A1 Trans-4-[[(5s)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2h-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid |
| 01/06/2011 | WO2011002606A1 Methods of identifying a patient population eligible for treatment with nitric oxide via inhalation |
| 01/06/2011 | WO2011002011A1 Combined medicine of sglt1 inhibitor and dpp-iv inhibitor |
| 01/06/2011 | WO2011002001A1 Combined medicine of pyrazole derivative and biguanide drug |
| 01/06/2011 | WO2011001913A1 Ppar ligand |
| 01/06/2011 | WO2011001440A1 Pharmaceutical compositions of valsartan |
| 01/06/2011 | WO2011001202A1 Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application |
| 01/06/2011 | WO2010130785A3 Novel use of probiotics |
| 01/06/2011 | WO2010130773A3 Benzoxazolone derivatives as aldosterone symthase inhibitors |
| 01/06/2011 | WO2010099319A3 Composition and methods for clotting blood |
| 01/06/2011 | WO2010098625A3 Pharmaceutical preparation |
| 01/06/2011 | WO2010056985A8 Treatment of proteinopathies using a farnesyl transferase inhibitor |
| 01/06/2011 | WO2009144093A8 Hydroxytyrosol benefits mitochondria |
| 01/06/2011 | US20110004006 Aminocyclohexyl ether compounds and uses thereof |